FDA Approves Humanwell Healthcare Unit’s Omega-3 Ethyl Ester Capsules
Xu Wei
DATE: Jun 16 2020
/SOURCE: Yicai
FDA Approves Humanwell Healthcare Unit’s Omega-3 Ethyl Ester Capsules
(Yicai Global) June 16 -- Puracap Pharmaceutical, a firm majority owned by Humanwell Healthcare Group, has received approval from the US Food and Drug Administration to sell Omega-3-acid ethyl ester capsules in the US.
Omega-3-acid ethyl ester capsules are primarily used to reduce hypertriglyceridemia in low-fat diets.